OpenResearchAlpha

Current Opinion in Clinical Nutrition & Metabolic Care · 6 Nov 2026

Sarcopenic obesity: definition, pathophysiology, and intervention strategies

Christelle Guillet, Audrey Embry, Alexandre Pinel, Yves Boirieh-index 69

0
Citations
no database records one yet
0
Citations in 2026
so far
69
Leading author's h-index
Yves Boirie, in QAI's scholar index
30
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0
  • Europe PMC0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Purpose of review Sarcopenic obesity (SO) is increasingly recognized as a clinically relevant condition associated with functional impairment, cardiometabolic complications, disability and mortality. However, its diagnosis remains challenging because of heterogeneous definitions, uncertain thresholds, and limited accessibility of body composition assessment in routine clinical practice. This review summarizes recent advances and remaining challenges in the characterization and management of SO. Recent findings Recent studies have contributed to a better understanding of the epidemiology, clinical consequences and multifactorial pathophysiology of SO, highlighting the importance of muscle quality and the interplay between adipose tissue, skeletal muscle, immune, endocrine and metabolic pathways. Emerging approaches, including pragmatic functional screening tools, innovative phenotype index and artificial intelligence, may improve disease characterization and risk stratification, although further validation is needed. Multicomponent lifestyle interventions combining exercise and nutritional optimization remain the mainstay of management, while incretin-based therapies raise new questions regarding muscle preservation and weight cycling. Summary SO remains a heterogeneous and incompletely characterized condition. Progress toward clinical implementation will require greater harmonization of diagnostic approaches, validation of emerging tools, and intervention trials assessing muscle-related and patient-centred outcomes.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Yves Boirie has the highest h-index among the authors (69).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (4)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (30)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 10 more references

A free account opens the rest of the citing papers and references on every paper’s page.

Sarcopenic obesity: definition, pathophysiology, and intervention strategies - QAI OpenResearch